Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Antibody
    (2)
  • TNF
    (2)
  • Antibody-Drug Conjugates (ADCs)
    (1)
TargetMol | Tags By Application
  • ELISA
    (3)
  • Functional assay
    (3)
  • FCM
    (2)
  • FACS
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

belantamab mafodotin

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    3
    TargetMol | All_Pathways
  • Belantamab mafodotin
    GSK2857916, GSK 2857916, Belantamab mafodotin-blm
    T779032050232-20-5
    Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate targeting B-cell maturation antigen (BCMA) that enhances immune cell infiltration and activation within tumors and delays tumor growth. It is used in studies of multiple myeloma.
    • $297
    In Stock
    Size
    QTY
  • Belantamab
    GSK2857914
    T771292061894-48-0
    Belantamab (GSK2857914) is a humanized IgG1 monoclonal antibody against BCMA (TNFRSF17). Belantamab is a naked antibody to Belantamab mafodotin and can be used to synthesize antibody-active molecule conjugates (Belantamab mafodotin).
    • $263
    In Stock
    Size
    QTY
  • Belantamab (FUT-8 KO)
    T9901A-824
    Belantamab (FUT-8 KO) is a humanized IgG1 monoclonal antibody targeting BCMA (TNFRSF17). It exhibits strong ADCC activity and can be utilized to synthesize the antibody-drug conjugate (ADC), Belantamab mafodotin.
    • $280
    4-6 weeks
    Size
    QTY